Clarium Capital Management
Clarium Capital Management is a global macro hedge fund managed by Peter A. Thiel. The firm invests in the public equity, fixed income, and hedging markets across the globe primarily investing in the stocks of micro-cap companies, distressed debt, commodities, bonds, currencies, and private investments employing an opportunistic approach. Clarium Capital Management was founded in 1998 and is based in San Francisco, CA.
View Older Stories View More Recent Stories
-
10 Top Penny Stocks On Robinhood To Watch Right Now Before July 2021
-
Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq debut
-
Fintech Wise to pioneer direct listing in boost to London
-
Wejo to go public, deal values auto data startup at $800 million
-
Narya and Peter Thiel Lead Investment in Rumble
-
Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology
-
The Miracle Compound Tackling A Trillion Dollar Crisis
-
Penny Stocks On Robinhood For You May 2021 Watch List
-
Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
-
Block.one and Prominent Investors Launch Bullish Global With $10B in Funding, and Announce the 2021 Launch of New Cryptocurrency Exchange, Bullish
-
Palantir to take bitcoin as payment, mulls betting on cryptocurrencies
-
U.S. chip startups, long shunned in favor of internet bets, stir excitement again
-
Forge Closes Over $150M in Funding, Adds New Investors Amid Another Record-Breaking Quarter
-
Lidar maker AEye valuation slips to $1.5 billion on new SPAC merger terms
-
Exclusive: Brazil's Nubank readies U.S. stock market listing - sources
-
Narrative adds Invisibly's Approved Audience Data to its Data Streaming Platform
-
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
-
Free Webinar: Battling Deep Fakes and Misinformation – Media’s Role and Responsibility
-
Free Webinar: Battling Deep Fakes and Misinformation – Media’s Role and Responsibility
-
Peter Thiel Said Bitcoin Could Be 'Chinese Financial Weapon' Against U.S. - Bloomberg
-
Alloy Therapeutics Raises $75 Million in Series C Financing to Advance Collaborative Biotechnology Ecosystem
-
Best Penny Stocks To Watch As Psychedelic Stocks Bloom In 2021
-
AbCellera Reports Full Year 2020 Business Results
-
Exclusive: Business payments firm AvidXchange preps for IPO, eyeing $7 billion valuation - sources
-
N26 appoints Silicon Valley entrepreneur Gilles BianRosa as Chief Product Officer
-
Nanotronics Appoints Jodi Shelton, Global Semiconductor Alliance co-founder and CEO, to Board of Advisors
-
Flex Logix Raises $55M Series D Financing As It Accelerates Market Adoption of AI Inference and eFPGA Solutions
-
Top Psychedelic Penny Stocks To Watch After Latest Big Pharma Deal
-
Genesis Prize Co-Founder Stan Polovets Steps Down as Chairman of Anchiano Therapeutics after Company Posts 630% Return in 12 Months
-
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
-
Chemomab Completes Merger with Anchiano Therapeutics
-
SafeGraph Raises $45M Series B to Become the Ultimate Destination for Physical Places Data
-
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
-
ForSight Robotics Raises $10 Million from Eclipse Ventures and Mithril Capital in Seed Round
-
Exclusive: Forward Health valued at over $1 billion in latest funding from SoftBank, others - source
-
N26 Launches Frictionless U.S. Rewards Program to Help Customers Easily Earn Cash Back with Everyday Spending
-
Psychedelics & Cannabis Have Triggered A Mad Dash In The Market & 1 Company Stands To Capitalize
-
Neobroker nextmarkets receives $30 million in Series B funding round
-
Alphabet-backed Oscar Health valued at $7.09 billion in lackluster debut
-
Peter Thiel Sold Half a Billion in Palantir (PLTR) Stock as Lockup Expired
-
BlackSky to Come Public on Merger with SPAC Osprey Technology Acquisition Corp. (SFTW)
-
BlackSky, a Leading Real-Time Geospatial Intelligence, Imagery and Data Analytics Company, to List on NYSE Through a Merger With Osprey Technology Acquisition Corp.
-
Big data firm Palantir signals slower annual revenue growth, shares fall
-
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
-
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
-
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
-
Forge Launches Forge Company Solutions To Help Private Companies Run Customized Liquidity Events
-
Chemomab Announces First Patient Enrolled in Phase IIa Study of CM-101 for the Treatment of Patients with Primary Sclerosing Cholangitis
-
Forge Appoints Head of Data to Expand Accuracy and Transparency for Private Market Companies and Investors
-
N26 celebrates 7 million customers globally

